Detalhe da pesquisa
1.
ABHD17 regulation of plasma membrane palmitoylation and N-Ras-dependent cancer growth.
Nat Chem Biol
; 17(8): 856-864, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33927411
2.
Chemical proteomic analysis of palmostatin beta-lactone analogs that affect N-Ras palmitoylation.
Bioorg Med Chem Lett
; 53: 128414, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34666187
3.
A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells.
Immunity
; 34(3): 327-39, 2011 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21376639
4.
T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire.
Immunity
; 31(1): 60-71, 2009 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19592274
5.
Vß2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen.
Proc Natl Acad Sci U S A
; 108(47): 19007-12, 2011 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22065767
6.
Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex.
J Biol Chem
; 287(46): 39139-48, 2012 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22995911
7.
Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands.
EMBO J
; 28(22): 3579-90, 2009 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-19816402
8.
Lysosomal processing of sulfatide analogs alters target NKT cell specificity and immune responses in cancer.
J Clin Invest
; 134(4)2023 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127463
9.
A single-domain bispecific antibody targeting CD1d and the NKT T-cell receptor induces a potent antitumor response.
Nat Cancer
; 1(11): 1054-1065, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35122066
10.
Natural Sphingomonas glycolipids vary greatly in their ability to activate natural killer T cells.
Chem Biol
; 15(7): 654-64, 2008 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-18635002
11.
Synthesis and evaluation of 3''- and 4''-deoxy and -fluoro analogs of the immunostimulatory glycolipid, KRN7000.
Bioorg Med Chem Lett
; 19(15): 4122-5, 2009 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19535248
12.
Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands.
EMBO J
; 28(23): 3781, 2009 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-19953109
13.
Mrp1 is involved in lipid presentation and iNKT cell activation by Streptococcus pneumoniae.
Nat Commun
; 9(1): 4279, 2018 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323255
14.
Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity.
Cell Chem Biol
; 25(5): 571-584.e8, 2018 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29576533
15.
Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens.
Nat Commun
; 7: 10570, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26875526
16.
Combination of paclitaxel and nitric oxide as a novel treatment for the reduction of restenosis.
J Med Chem
; 47(9): 2276-82, 2004 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-15084126
17.
Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles.
J Med Chem
; 47(9): 2180-93, 2004 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-15084117
18.
Cloning and characterization of a hybridoma secreting a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-specific monoclonal antibody and recombinant F(ab).
Toxins (Basel)
; 5(3): 568-89, 2013 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23518474
19.
Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity.
Cell Chem Biol
; 25(7): 925, 2018 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30028975
20.
A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.
J Exp Med
; 205(4): 939-49, 2008 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-18378792